Published by Josh White on 26th February 2019
(Sharecast News) - Midatech Pharma confirmed on Tuesday that, following shareholder approval of the strategic investment by China Medical Systems (CMS) and A&B Hong Kong, the licence agreement entered into between itself and CMS was now formally in force.
URL: http://www.digitallook.com/dl/news/story/28683948/...